Skip to main content
SpringerLink
Log in

NICE issues final guidance on three treatments

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE issues final guidance on pomalidomide (Imnovid) for blood cancer. Media Release : 25 Mar 2015. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE recommends rivaroxaban (Xarelto) to prevent blood clots in people who have had a heart attack. Media Release : 25 Mar 2015. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE recommends treatment for brain condition caused by liver failure - 25 Mar 2015. Media Release : 25 Mar 2015. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE issues final guidance on three treatments. PharmacoEcon Outcomes News 725, 33 (2015). https://doi.org/10.1007/s40274-015-2047-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2047-4

Search

Navigation